Lumenis Executive and Leadership Team

Tzipi Ozer-Armon, the Chief Executive Officer at Lumenis, directs the company's overall strategic vision and operational execution. This leadership role involves guiding Lumenis's mission to develop and commercialize advanced energy-based technologies for skin, body, and eye care treatments. Ozer-Armon oversees all global business units, ensuring alignment with market demands and technological advancements in the aesthetics and medical device sectors. The Chief Executive Officer's responsibilities include fostering innovation, driving sustainable growth, and maintaining Lumenis's position as a leader in its field. Tzipi Ozer-Armon's strategic direction ensures the company's continued impact on patient outcomes and practitioner success worldwide.

Shy Basson, the Chief Financial Officer at Lumenis, manages the company's financial health and strategic fiscal planning. This executive function encompasses overseeing all financial operations, including accounting, budgeting, forecasting, and investor relations. Basson ensures robust financial controls and compliance with regulatory requirements across global markets. The Chief Financial Officer's role is critical in supporting Lumenis's growth initiatives by securing funding, optimizing capital allocation, and driving profitability. Shy Basson's financial acumen directly supports the company's ability to invest in research and development for its energy-based technologies in skin, body, and eye care treatments.

Brad Oliver, the President & General Manager (Americas) at Lumenis, directs all commercial operations and strategic initiatives across North and South America. This executive function involves overseeing sales, marketing, and customer support for Lumenis's comprehensive range of energy-based technologies in skin, body, and eye care. Oliver is responsible for driving market penetration, achieving revenue targets, and expanding Lumenis's presence within the Americas region. The President & General Manager's leadership ensures seamless execution of business strategies and fosters strong relationships with healthcare providers and partners. Brad Oliver's regional oversight is pivotal to Lumenis's sustained growth and market leadership in the Americas.

Stacey Winter, the President, North America at Lumenis, leads the strategic direction and commercial execution for the company's operations within the North American market. This executive role encompasses driving sales growth, enhancing market share, and ensuring customer satisfaction across all product lines, including skin, body, and eye care treatments. Winter oversees the regional leadership teams, fostering a culture of performance and innovation. The President, North America's responsibilities include developing and implementing market-specific strategies that align with Lumenis's global objectives. Stacey Winter's leadership is instrumental in strengthening Lumenis's brand presence and commercial success throughout the United States and Canada.

Tahel Blum, the Chief Information Officer at Lumenis, architects and executes the company's global information technology strategy. This leadership position involves overseeing all aspects of IT infrastructure, cybersecurity, data management, and digital transformation initiatives. Blum ensures that Lumenis's technology systems effectively support its business objectives, including the development and commercialization of energy-based medical technologies. The Chief Information Officer's focus is on enhancing operational efficiency, driving innovation through technology, and safeguarding sensitive company and customer data. Tahel Blum's strategic IT leadership enables Lumenis to maintain a competitive edge in the dynamic healthcare technology landscape.

Assaf Preiss, the Vice President, Aesthetics Research Development & Chief Technology Officer at Lumenis, spearheads the innovation pipeline for the company's aesthetic product portfolio. This critical role involves leading the research and development efforts for new energy-based technologies and enhancing existing solutions for skin and body treatments. Preiss directs teams focused on scientific discovery, product engineering, and technological advancement, ensuring Lumenis remains at the forefront of aesthetic medicine. The Chief Technology Officer's mandate includes translating cutting-edge research into commercially viable products that meet evolving market needs. Assaf Preiss's technical leadership drives the development of groundbreaking treatments and solidifies Lumenis's reputation for technological excellence.

Rani Hagag, the Group Vice President, Aesthetic Business at Lumenis, spearheads the strategic development and commercial success of the company's aesthetic product portfolio. This leadership position involves overseeing all aspects of the aesthetic business unit, from product lifecycle management to market expansion. Hagag drives initiatives aimed at increasing revenue, enhancing product offerings, and solidifying Lumenis's market leadership in aesthetic energy-based technologies. The Group Vice President's focus is on identifying new market opportunities and ensuring the effective delivery of innovative solutions to customers. Rani Hagag's strategic guidance is crucial for the sustained growth and competitive positioning of Lumenis's aesthetic division globally.